- Home
- LOVE vs VRCA Comparison
LOVE vs VRCA Comparison
Compare LOVE & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOVE
- VRCA
- Stock Information
- Founded
- LOVE 1998
- VRCA 2013
- Country
- LOVE United States
- VRCA United States
- Employees
- LOVE N/A
- VRCA N/A
- Industry
- LOVE Other Specialty Stores
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- LOVE Consumer Discretionary
- VRCA Health Care
- Exchange
- LOVE Nasdaq
- VRCA Nasdaq
- Market Cap
- LOVE 452.6M
- VRCA 363.1M
- IPO Year
- LOVE 2018
- VRCA 2018
- Fundamental
- Price
- LOVE $30.35
- VRCA $0.83
- Analyst Decision
- LOVE Strong Buy
- VRCA Buy
- Analyst Count
- LOVE 5
- VRCA 6
- Target Price
- LOVE $33.80
- VRCA $7.33
- AVG Volume (30 Days)
- LOVE 265.5K
- VRCA 712.9K
- Earning Date
- LOVE 12-04-2024
- VRCA 11-04-2024
- Dividend Yield
- LOVE N/A
- VRCA N/A
- EPS Growth
- LOVE N/A
- VRCA N/A
- EPS
- LOVE 0.59
- VRCA N/A
- Revenue
- LOVE $693,776,000.00
- VRCA $9,210,000.00
- Revenue This Year
- LOVE $3.84
- VRCA $291.12
- Revenue Next Year
- LOVE $7.02
- VRCA $104.31
- P/E Ratio
- LOVE $51.64
- VRCA N/A
- Revenue Growth
- LOVE 3.71
- VRCA 187.45
- 52 Week Low
- LOVE $16.20
- VRCA $0.70
- 52 Week High
- LOVE $31.69
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- LOVE 60.79
- VRCA 31.67
- Support Level
- LOVE $29.10
- VRCA $0.70
- Resistance Level
- LOVE $31.69
- VRCA $1.74
- Average True Range (ATR)
- LOVE 1.24
- VRCA 0.13
- MACD
- LOVE -0.03
- VRCA -0.06
- Stochastic Oscillator
- LOVE 63.08
- VRCA 12.18
About LOVE The Lovesac Company
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.